# FDA Inspection 1008224 - Antares Pharma Inc. - February 27, 2017

Source: https://www.keypedia.com/records/fda_inspections/antares-pharma-inc/b99d1b49-898b-4bd9-92a4-e27f1c50d162
Source feed: FDA_Inspections

> FDA Inspection 1008224 for Antares Pharma Inc. on February 27, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1008224
- Company Name: Antares Pharma Inc.
- Inspection Date: 2017-02-27
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 804154 - 2012-08-20](https://www.keypedia.com/records/fda_inspections/antares-pharma-inc/7abff28b-bcbe-4f8e-8466-42bf01680308)

Company: https://www.keypedia.com/companies/antares-pharma-inc/ceac69c4-dc16-49fc-934c-a6fd6fc34a20

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c